Magnesium for Childhood Constipation: When Magnesium Hydroxide or Oxide Is the Right Call

Functional constipation affects up to 30 percent of children at some point. The first-line maintenance treatment in pediatric gastroenterology guidelines is polyethylene glycol 3350 (PEG), but magnesium-based osmotic laxatives — milk of magnesia (magnesium hydroxide) and magnesium oxide — remain widely used, particularly in families that prefer to avoid prescription products or in countries where PEG is less available. The trial evidence supports them as effective alternatives, with specific cautions about kidney function and toxicity at high doses.

Mechanism: osmotic, not stimulant

Magnesium salts are poorly absorbed in the gut. Unabsorbed magnesium ions draw water into the intestinal lumen by osmotic gradient, softening stool and accelerating transit. This is fundamentally different from senna or bisacodyl, which directly stimulate enteric nerves. Osmotic laxatives are generally safer for chronic use in children because they do not cause tachyphylaxis, do not damage the myenteric plexus, and do not produce significant cramping when titrated to soft stool.

Pediatric efficacy trials

The pivotal head-to-head trial was Loening-Baucke 2006 in 100 children aged 4 to 16, randomized to PEG 3350 (0.7 g/kg/day) or magnesium hydroxide (0.5 mL/kg/day of 800 mg/5 mL suspension). Both groups improved over 4 weeks; PEG produced slightly higher rates of treatment success (62 vs 43 percent) but magnesium hydroxide was effective and tolerated [1]. A 2017 systematic review by Gordon and colleagues pooled multiple trials and concluded that PEG is more effective than placebo and at least as effective as lactulose or magnesium hydroxide, with magnesium agents serving as a reasonable second-line option [2].

Practical pediatric dosing

For magnesium hydroxide suspension (400 mg/5 mL), typical starting doses are 1 to 3 mL/kg/day in divided doses, titrated to soft stool. For magnesium oxide tablets (commonly used in Japan in pediatric constipation), 30 to 60 mg/kg/day is the usual range, divided into 2 to 3 doses. Onset is typically 6 to 24 hours. Parents should be coached that producing soft (not liquid) stool once or twice daily is the target, not maximum laxation.

When magnesium is the wrong choice

Children with reduced kidney function cannot clear absorbed magnesium and are at risk of hypermagnesemia, which can cause hypotension, bradycardia, respiratory depression, and cardiac arrest at extreme levels [3]. The FDA and AAP have specifically warned about magnesium-containing laxatives in children with renal impairment or in any child receiving very high doses. Magnesium oxide overdose in Japanese pediatric reports has caused hypermagnesemia, with children with bowel obstruction, perforation, or impaired renal clearance most at risk [4]. Children with neurologic constipation due to slow transit may benefit more from PEG plus prokinetic strategies; pure osmotic therapy may be insufficient.

How it compares to PEG

PEG 3350 has the largest trial base in pediatric chronic constipation and is the AAP/NASPGHAN first-line recommendation. It is tasteless when mixed in liquid, generally well tolerated, and not absorbed at all. Magnesium hydroxide is the historical alternative and is reasonable when families decline PEG, when PEG is unavailable, or for short-term acute constipation. Stimulant laxatives (senna, bisacodyl) should be reserved for short-term rescue, not maintenance.

Other roles for magnesium in children

Magnesium for childhood anxiety, ADHD, or sleep has much weaker evidence than for constipation. The constipation use case is well-established and grounded in mechanism plus head-to-head trials. Discussion with a pediatrician before starting chronic laxative therapy is advisable, particularly in any child with abdominal pain, weight loss, or developmental delay.